CD1D and colitis: Additional studies have provided evidence that CD1d-dependent pathogenic iNKT cell activation by commensal-derived glycolipid Ags can be inhibited by competitive CD1d binding with globotriaosylceramide (44) and α-lactosylceramide (45) during iNKT cell-mediated Oxa-induced colitis.